Frequent blood flow restricted training not to failure and to failure induces similar gains in myonuclei and muscle mass by Bjørnsen, Thomas et al.
1420 |    Scand J Med Sci Sports. 2021;31:1420–1439.wileyonlinelibrary.com/journal/sms
Received: 17 February 2020 | Revised: 15 February 2021 | Accepted: 4 March 2021
DOI: 10.1111/sms.13952  
O R I G I N A L  A R T I C L E
Frequent blood flow restricted training not to failure and to 
failure induces similar gains in myonuclei and muscle mass
Thomas Bjørnsen1,2  |   Mathias Wernbom3,4 |   Gøran Paulsen2,5 |   Sveinung Berntsen1 |   
Robert Brankovic1 |   Håkon Stålesen1 |   Joakim Sundnes1 |   Truls Raastad3
This is an open access article under the terms of the Creative Commons Attribution License, which permits use, distribution and reproduction in any medium, provided the original 
work is properly cited.
© 2021 The Authors. Scandinavian Journal of Medicine & Science In Sports published by John Wiley & Sons Ltd.
Funding information 
We received no funding for this study.  
1Department of Sport Science and 
Physical Education, Faculty of Health 
and Sport Sciences, University of Agder, 
Kristiansand, Norway
2Norwegian Olympic Federation, Oslo, 
Norway
3Center for Health and Performance, 
Department of Food and Nutrition, and 
Sport Science, University of Gothenburg, 
Göteborg, Sweden
4Department of Health and 
Rehabilitation, Institute of Neuroscience 
and Physiology, Sahlgrenska Academy, 
University of Gothenburg, Göteborg, 
Sweden
5Department of Physical Performance, 
Norwegian School of Sport Sciences, 
Oslo, Norway
Correspondence
Thomas Bjørnsen, University of Agder, 
Faculty of Sports and Health Sciences, 
PO. Box 422, 4604 Kristiansand, Norway.
Email: thomas.bjornsen@uia.no
Abstract
The purpose of the present study was to compare the effects of short- term high- 
frequency failure vs non- failure blood flow– restricted resistance exercise (BFRRE) 
on changes in satellite cells (SCs), myonuclei, muscle size, and strength. Seventeen 
untrained men performed four sets of BFRRE to failure (Failure) with one leg and 
not to failure (Non- failure; 30- 15- 15- 15 repetitions) with the other leg using knee- 
extensions at 20% of one repetition maximum (1RM). Fourteen sessions were dis-
tributed over two 5- day blocks, separated by a 10- day rest period. Muscle samples 
obtained before, at mid- training, and 10- day post- intervention (Post10) were analyzed 
for muscle fiber area (MFA), myonuclei, and SC. Muscle size and echo intensity 
of m.rectus femoris (RF) and m.vastus lateralis (VL) were measured by ultrasonog-
raphy, and knee extension strength with 1RM and maximal isometric contraction 
(MVC) up until Post24. Both protocols increased myonuclear numbers in type- 1 
(12%– 17%) and type- 2 fibers (20%– 23%), and SC in type- 1 (92%– 134%) and type- 2 
fibers (23%– 48%) at Post10 (p < 0.05). RF and VL size increased by 5%– 10% in both 
legs at Post10 to Post24, whereas the MFA of type- 1 fibers in Failure was decreased 
at Post10 (−10 ± 16%; p = 0.02). Echo intensity increased by ~20% in both legs 
during Block1 (p < 0.001) and was ~8 to 11% below baseline at Post24 (p = 0.001– 
0.002). MVC and 1RM decreased by 5%– 10% after Block1, but increased in both 
legs by 6%– 11% at Post24 (p < 0.05). In conclusion, both short- term high- frequency 
failure and non- failure BFRRE induced increases in SCs, in myonuclei content, mus-
cle size, and strength, concomitant with decreased echo intensity. Intriguingly, the 
responses were delayed and peaked 10– 24 days after the training intervention. Our 
findings may shed light on the mechanisms involved in resistance exercise- induced 
overreaching and supercompensation.
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1 |  INTRODUCTION
Low- load resistance training at 20%– 50% of the one repe-
tition maximum (1RM) combined with blood flow restric-
tion (BFR) can be used to achieve hypertrophic and strength 
responses similar to traditional high- load non- restricted 
strength training.1,2 This has applications for individuals 
who may not tolerate the mechanical stresses associated with 
higher load strength training, and/or athletes who seek to fa-
cilitate muscular development without adding substantially 
to the total training dose experienced.1,3
Blood flow– restricted resistance exercise performed 
with multiple sets to voluntary failure can induce high rat-
ings of perceived pain, - exertion, and delayed onset mus-
cle soreness (DOMS),4 as well as other signs of muscle 
damage in unaccustomed individuals.5 However, perceived 
pain seems to be reduced if volitional failure is not reached 
in the exercising sets.6 Furthermore, reaching voluntary 
failure does not seem to be required to promote increases 
in muscle size and strength during BFRRE6; hence, non- 
failure BFRRE may be more feasible if it efficiently pro-
duces increases in muscle size and strength with reduced 
perceptions of exertion and discomfort. To the best of our 
knowledge, no previous study has investigated the influ-
ence of exertion during short- term high- frequency blocks 
of low- load BFRRE on the training adaptations and percep-
tual responses.
The precise mechanisms involved in muscle adaptations 
to BFRRE are still not completely elucidated. However, sat-
ellite cell (SC) activation, proliferation, and subsequent addi-
tion of new myonuclei have recently been implicated in the 
hypertrophic response observed with low- load BFRRE.3,4,7 
We recently investigated if a rest period could reset the re-
sponsiveness of the myofibers after an initial high- frequency 
(twice daily) training block similar to Nielsen et al,7 and 
consequently allow the muscle fibers to respond to a second 
block of BFRRE by further increases in SCs, myonuclei, and 
hypertrophy.4 In line with the findings by Nielsen and co- 
workers, we observed robust increases in SC and myonuclear 
numbers, along with gains in muscle size and strength.4
Importantly though, our results also suggested that these 
processes can be delayed with very strenuous high- frequency 
BFRRE, as the increases in SC, myonuclei, muscle size, and 
strength did not peak until 10– 20 days after the last training 
session. Furthermore, we observed prolonged reductions in 
strength (>5 days), relatively high overall increases in circu-
lating markers of muscle damage, and transient muscle fiber 
atrophy despite increases in muscle thickness after the ini-
tial week of frequent BFRRE, altogether indicating excessive 
myofiber stress. The discrepancies between our findings4 and 
Nielsen et al.7 may originate from a greater degree of effort 
and a higher training volume in our study, especially during 
the first week of training (80 vs 52 repetitions per session).
Therefore, the purpose of the present study was to com-
pare the effects of a failure versus a non- failure BFRRE pro-
tocol on myonuclear and SC numbers as well as muscle size 
and strength, and the time courses of the changes, during two 
blocks with high- frequency BFRRE separated by 10 days of 
rest. We hypothesized that the non- failure protocol would in-
duce larger increases in myofiber areas and in the numbers of 
SC and myonuclei after the first training block compared to 
the failure protocol.
Intriguingly, the SC, myonuclear responses and myofiber 
hypertrophy in Nielsen et al.7 appeared to plateau already 
after one week of training (seven sessions), with no fur-
ther increases after two subsequent high- frequency blocks. 
Therefore, we also hypothesized that the 10- day rest period 
would resensitize the myofibers, so that in contrast to the pla-
teau observed after the first seven training session by Nielsen 
et al.,7 further increases in whole muscle areas, myonuclear, 
and SC numbers would be expected to take place with the 
second training block.
2 |  METHODS
2.1 | Participants
Eighteen healthy untrained men were recruited from the 
University of Agder in Kristiansand; Norway. To be in-
cluded in the study, participants should not have participated 
in regular strength training (>1 session every week) of their 
thigh muscles the last 6 months or had any prior experience 
with BFRRE. The participants were instructed to refrain 
from strenuous activities and maintain their usual food in-
take during the intervention. Exclusion criteria were any in-
juries in the musculoskeletal system that could prevent the 
participants from training or testing, as well as any use of 
medication and/or supplements (eg, protein powder, vita-
mins, creatine, NSAIDs, etc.). The study complied with the 
standards set by the Declaration of Helsinki and the ethical 
committee of the Faculty of Health and Sport Sciences at the 
University of Agder, as well as the Norwegian Centre for 
Research Data, approved the study. The nature and goals of 
the study were thoroughly explained, and all participants pro-
vided a written informed consent.
2.2 | Study design
The present study was conducted as a controlled experiment 
with stratified randomization (stratified based on 1RM test 
results) between the right and left leg of the participants, to 
train with a failure protocol with one leg, and the other leg to a 
non- failure protocol. A total of 14 low- load BFRRE sessions 
were conducted, including seven BFRRE sessions in 5 days 
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during the first block, followed by 10 days of rest, and then 
additionally seven more BFRRE sessions in the next 5 days 
(Figure 1). One BFRRE session per day was performed the 
first 3 days of each training block, and then two sessions per 
day the following two days, separated by at least 4 hours.7 
Subjects received 20  g of whey protein (Proteinfabrikken 
AS, Stokke, Norway) after every training session to ensure 
sufficient protein balance and maximize the hypertrophic 
response to the training. One week prior to the intervention 
period, subjects underwent a familiarization session in which 
they practiced knee extensions (without BFR) and strength 
tests. Machine settings (seat position) were noted and stand-
ardized for each participant. Muscle biopsies were obtained 
from m. vastus lateralis (VL) from both legs at baseline, 
2 hours after the first BFRRE session (“Acute1”, Day1), at 
rest during the Rest Week (“Rest Week”: five days after the 
7th BFRRE session) and 10  days after the second training 
block (“Post10”). Participants arrived fasted in the morn-
ings before muscle biopsies were obtained and were served a 
standardized breakfast consisting of oatmeal (0.16 g protein/
kg bodyweight) mixed with sugar (6 g) and water 2 hours 
before the biopsies were sampled. Increases in the blood con-
centrations of creatine kinase and myoglobin and decrements 
in force can be used as indirect markers of myocellular stress 
and “overreaching”.8,9 Furthermore, increases in muscle 
echo intensity on ultrasound images may be an indicator of 
edema- related muscle swelling10 and/or fibrosis,11 whereas 
others have suggested that decreases in echo intensity reflect 
an improved muscle quality.12 Consequently, blood samples 
and regular measurements of muscle strength and echo inten-
sity were included in this study.
Muscle function, muscle size, and echo intensity were 
evaluated at baseline, during the Rest Week, and at 3, 10, 
17, and 24  days after the second BFRRE block (“Post3” 
to “Post24”, Figure  1). Muscle size and echo intensity (by 
ultrasonography) were also measured every other training 
day before the training sessions, and muscle soreness, per-
ceived pain, and - exertion were registered every training 
day and at the Rest Week. In addition, maximal voluntary 
isometric contraction (MVC) was evaluated one hour before 
and two hours after BFRRE at Acute1 (Day1) and Acute2 
(Day15). Measures of body composition were performed 
with the subjects in a fasted state at baseline with InBody 720 
(InBody body composition analyzer, Biospace, Korea). Each 
test was conducted by a single investigator and done in the 
same order during each visit to maintain consistency.
2.3 | Blood flow restricted resistance exercise
Training was conducted in a unilateral knee extension ma-
chine (G200 Knee Extension, David health solutions LTD, 
Helsinki, Finland) at 20% of 1RM. The non- failure exercise 
protocol consisted of 75 repetitions distributed over four sets 
(30, 15, 15, 15), while the failure protocol consisted of four 
sets performed to voluntary failure. The right leg was exer-
cised before the left with a 5- minute break in between. A 
145- mm- wide pressure cuff with a 12- cm bladder (9- 7359- 
003, Delfi Medical, Vancouver BC, Canada) was placed 
around the proximal part of the thigh and inflated by a tour-
niquet system (Zimmer A.T.S. 2000, Warsaw, IN, USA) to 
100 mm Hg before initiation of BFRRE (similar to Bjørnsen 
et al.4 and Nielsen et al.7). The pressure was adjusted continu-
ously during the exercise to remain at 100 mm Hg. We have 
previously observed a reasonably narrow range (54%– 64%) 
of the pressure needed to fully occlude blood flow of a. femo-
ralis superficialis with this same equipment and pressure in 
young participants.4 Repetitions were performed with a 1 sec-
ond concentric phase and a 1 second eccentric phase. Warm 
up consisted of 15 repetitions of 5 kg resistance performed 
F I G U R E  1  Schematic illustration of the study design. White arrows denote individual training sessions. Refer the Methods section for more 
details. BFRRE, blood flow restricted resistance exercise; EMG, electromyography; MVC, maximal voluntary isometric contraction
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without BFR. During BFRRE, the cuff was kept inflated 
and released immediately upon completion of the fourth set. 
Range of motion was set from 100° to 10° (0° = full exten-
sion). To ensure maximal performance, all participants were 
given verbal motivation during each training session.
2.4 | Strength testing
Muscle function was evaluated by testing MVC and 1RM in 
the same unilateral knee extension machine during BFRRE. 
General warm- up consisted of 5  minutes cycling on a sta-
tionary ergometer bike (Monark Ergomedic 839E, Monark 
Exercise AB, Varberg, Sweden) with a standardized load 
(100 watt at 80- 90RPM), followed by a specific warm- up 
for MVC by four submaximal isometric contractions (aimed 
at 50%, 60%, 80%, and 90% of a maximal contraction). The 
MVC test was conducted with a knee angle of 90 degrees, 
with three maximal isometric contractions each lasting for 
5 seconds, 2 minutes rest between attempts and 60 seconds 
rest between legs. The trial with the highest torque was se-
lected for further analysis. After MVC tests, specific warm-
 up to the 1RM test was conducted and consisted of four sets 
in total, with 10 repetitions at 50% of the estimated 1RM, 
six repetitions at 70% of 1RM, three repetitions at 80% of 
1RM and one repetition at 90% of 1RM, respectively. After 
this, single repetitions with increasingly heavier load were 
performed until the 1RM load was found (minimum 1.25 kg 
increments), that is, the highest load that could be lifted 
throughout the range of motion. Two- minute rests were 
given between each 1RM attempt and at least 60  seconds 
rest between each leg. The right leg was always tested first. 
The lift was approved if the knee joint reached an angle of 
10° (0°  =  full extension). Participants were secured to the 
chair by a seat belt around the waist and their hands placed 
on handles on the side of the chair at both the MVC and 1RM 
measurements. Strong verbal motivation was given during 
the tests.
2.5 | Ultrasonography
Muscle size and echo intensity were assessed using a bright-
ness mode (B- mode) ultrasonography apparatus (LogicScan 
128 XEXT- 1Z kit, Telemed, LT), with linear probe of 4 mm 
width and an excitation frequency of 9  MHz. Ultrasound 
settings of focus, depth, dynamic range, power, gain, and 
frequency were optimized to identify the muscle aponeuro-
sis and then kept constant for all measurement time points. 
Ultrasound measurements of muscle thickness in m. rec-
tus femoris (RF), m. vastus lateralis (VL), and the anterior 
portion of m. vastus intermedius (VI), as well as the cross- 
sectional area (CSA) of RF were obtained at a distance equal 
to 40% (distally) of the femur length from the lateral epicon-
dyle of the knee to the great trochanter major. Images were 
analyzed blindly in a random order by one examiner using 
the software ImageJ (Wayne Rasband, National Institutes of 
Health, Bethesda, MD, USA). Test– retest measurements of 
muscle size between the familiarization and baseline meas-
urements revealed coefficients of variation of 0.5%– 2% for 
muscle thickness and 2.9% for RF CSA.
Echo intensity was assessed by computer- aided gray- scale 
(0 and 256 arbitrary units [A.U.], black = 0; white = 256) 
analysis using the histogram function in ImageJ. The region 
of interest (ROI) was selected using the polygon function in-
cluding the largest ROI possible. The average of three pic-
tures per measurement site was used for further analysis. 
Test– retest measurements between the familiarization and 
baseline measurements revealed a coefficient of variation of 
6.2% for echo intensity in VL and 5.6% for echo intensity in 
RF.
2.6 | Muscle biopsy sampling
Muscle biopsies (~200– 300 mg) were obtained from m. vas-
tus lateralis using a 6- mm sterile Bergström needle (Pelomi, 
6  mm, Albertslund, Denmark) under local anesthesia 
(Xylocain- adrenaline, 10  mg/mL +5  µg/mL, AstraZeneca, 
Södertälje, Sweden). The incisions were taken ~3 cm apart 
to minimize the repeated biopsy effect, as it is demonstrated 
no result in an increased satellite cell content or pronounced 
changes in other markers of regeneration when sampling 
sites are separated by 3 cm and adhere to a somewhat similar 
time course as the present study (four biopsies from m.vastus 
lateralis within 30 days).13 Visible connective tissue and fat 
were dissected away before a bundle of fibers for later immu-
nohistochemical analyses was mounted in OCT Embedding 
Matrix (Tissue- tek, O.C.T. compound, Sakura, USA) and 
immediately frozen in isopentane, which was pre- cooled 
(−140°C) with liquid nitrogen and stored at −80°C for later 
analysis.
2.7 | Immunohistochemical staining
Muscle biopsies were cut to 8- µm- thick cross- sections 
at −20°C using a cryostat (CM 3050, Leica Biosystems 
GmbH, Wetzlar, Germany), mounted on microscope slides 
(Superfrost Plus, Menzel- Gläser, Braunschweig, Germany) 
air- dried at room temperature, and stored at −80°C. Before 
immunostaining, frozen sections were air- dried and sub-
sequently permeabilized with 0.1% Tween 20 in PBS for 
3 × 10 minutes and blocked with serum- free protein blocker 
(Dako, 10082504, Glostrup, Denmark) and PBS- t (PBS 
with 0.05% Tween 20) solution (QC213624, Thermo Fisher 
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Scientific, Carlsbad, CA, USA) for 10 minutes at room tem-
perature. Sections were incubated with primary antibodies 
for 60  minutes (room temperature) in a serum- free protein 
blocker (Dako, 10082504, Glostrup, Denmark), and PBS- t 
(PBS with 0.05% Tween 20) solution (QC213624, Thermo 
Fisher Scientific, Carlsbad, CA, USA), and incubated with 
secondary antibodies for 60  minutes at room temperature. 
SCs were visualized with antibodies against Neural Cell 
Adhesion Molecule (NCAM, ABCam, 153377- 1, Cambridge 
Science Park, Cambridge, UK, 1:200) together with laminin 
(Dako, 20025756, Glostrup, Denmark, 1:400) and DAPI- 
stains (for nuclear staining) (Invitrogen, 1266174, Carlsbad, 
CA, USA). Neighboring sections were stained for MHC- II 
(SC- 71c, DSHB, Iowa City, Iowa, USA, 1:1000) and dys-
trophin (Abcam, GR42138- 1, Cambridge, UK, 1:500) for 
identification of type II myofibers14 and delineation of the 
myofiber border, respectively, together with DAPI- stains. 
Specific secondary antibodies (Alexa- 488 goat anti- mouse 
[Invitrogen, 1008801, Carlsbad, CA, USA, 1:200] and CF- 594 
goat anti- rabbit [Invitrogen, 1008648, Carlsbad, CA, USA, 
1:200]) were applied after each primary antibody. Sections 
were mounted with a fluorescent anti- fade containing DAPI 
solution. The sections were visualized on a computer screen 
using a light microscope (Olympus BX61, Tokyo, Japan) 
connected to a fluorescent light (X- Cite 120PCQ; EXFO 
Photonic Solutions Inc., Mississauga, Ontario, Canada). The 
microscope was connected to a digital camera (Olympus 
DP72, Tokyo, Japan), and pictures were taken at 20× (SCs 
and myonuclei) and 4× (muscle fiber areas and fiber type) 
magnification. All morphometric analyses were performed 
in Cell- F (Olympus, Tokyo, Japan), TEMA (ChekVision, 
Hadsund, Denmark), and ImageJ. The criteria for identifying 
SCs were that they had to stain positive for NCAM, be placed 
within the basal lamina, and have a nucleus with a subordi-
nate placement (Figure  2). The analyses of SCs and MFA 
were conducted with an average of 545 ± 241 muscle fib-
ers, and with a minimum of 150 fibers. Myonuclei had to be 
stained for DAPI and be placed within the dystrophin stain-
ing, and 50 fibers were counted from each fiber type (50 fib-
ers with and without MHC- II/SC- 71c staining). Furthermore, 
nuclei with a central or internal position were counted; as an 
additional indicator of myofiber regeneration.15 Myonuclei 
and nuclei with an internal position in the myofiber were 
only counted in muscle fibers with intact staining around the 
whole fiber.
2.8 | Myoelectric activity during BFRRE
Myoelectric activity was measured with surface electromyo-
graphy (EMG, Trigno™ 103 Wireless Systems and Smart 
Sensors, Delsys, Boston, MA, USA) on VL and RF. After 
a skin preparation (shaving and alcohol rinse), two elec-
trodes (Blue sensor M, Ambu, Ballerup, Denmark; diameter: 
31 mm, interelectrode distance 10 mm) were placed on the 
distal parts of VL and RF, according to recommendations 
for sensor locations by SENIAM.16 EMG was recorded at 
2000 Hz (bandwidth 20– 450 Hz) and rectified and smoothed 
(100 ms moving average) with the root- mean- square (RMS) 
algorithm (hardware and software from Delsys, Boston, MA, 
USA, version 4.2). The peak EMG values during the concen-
tric phases from the average of the three first, middle, and last 
repetitions in each set of BFRRE were expressed relative to 
the peak EMG values during MVC measurements obtained 
1 hours before the BFRRE sessions at Acute 1 and 2, with the 
EMG electrodes still in place.
2.9 | Delayed- onset muscle soreness, 
perceived exertion and – pain
Delayed- onset muscle soreness (DOMS) was registered on a 
100- mm visual analogue scale17 before every BFRRE bout. 
Subjects were asked to quantify their DOMS by palpating 
their quadriceps with two fingers on five different locations 
on both legs: distal, middle, and proximal parts of the VL, 
then distal and middle parts of m. vastus medialis (VM). The 
measurement locations were recorded on transparent, acetate 
paper. Palpations were done in a standing position and par-
ticipants were familiarized to apply palpation pressures two 
times before the baseline measurements. The average of the 
five positions was used for further analysis. Subjects were 
F I G U R E  2  Representative 
immunohistochemical staining. White 
arrows denote NCAM+ satellite cell, yellow 
arrows denote NCAM+/Dapi+ satellite 
cell (A) NCAM and Laminin staining, (B) 
NCAM, Dapi and Laminin merged. The 
scale bar is 50 µm
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instructed to not include soreness or pain from the area that 
biopsies were obtained in the assessment. Test– retest DOMS 
measurements acquired before the intervention demonstrated 
limits of agreements (mean difference ±1.96 standard devia-
tions SD of the difference) of between 0.1– 0.7 ± 1.9– 3.6 mm 
at all measurement locations. Participants were asked to re-
port perceived pain (Borg CR10) and - exertion (Borg- RPE 
scale) immediately after every BFRRE bout, as they per-
ceived it during the exercise efforts.
2.10 | Blood samples
Changes in blood concentration of creatine kinase and myoglo-
bin were assessed to investigate indirect markers of myocellu-
lar stress and “overreaching” across legs in each participant.8,9 
Blood samples were obtained in a fasted state (≥12 hours) from 
resting individuals at baseline, the fourth day of BFRRE (Day 
4), as well as 2- and 4- hour post- BFRRE (not fasted) the first 
day of the first training block. Blood was drawn from an antecu-
bital vein into 8- mL serum vacutainer tubes. After 30 minutes, 
the tubes were centrifuged at 2100 g for 10 minutes at 4°C and 
serum was transferred to 1- mL blood collection tubes. Serum 
were immediately stored at −80°C until analysis. A Modular 
Analyzer P800 (Roche Diagnostics, Mannheim, Germany) was 
used to analyze creatine kinase and a Modular Analyzer E170 
(Roche Diagnostics, Mannheim, Germany) was used to assess 
myoglobin levels. Test– retest measurements revealed a coef-
ficient of variation of 5% creatine kinase and 6% for myoglobin 
analysis.
2.11 | Statistical analysis
With a minimum of 16 participants in each group, we had 
80% power to detect a mean group difference between the two 
F I G U R E  3  Number of repetitions, DOMS, perceived exertion and - pain. Number of repetitions (A) and perceived exertion (B) and - pain (C) 
per blood flow restricted resistance exercise (BFRRE) bout, as well as delayed muscle onset soreness (DOMS) (D), expressed on a timeline from 
the first day of BFRRE until 3 days after the intervention. * represents significant differences between legs (p < 0.05). Data are expressed as means 
with 95% confidence intervals
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groups of 10% in the number of myonuclei with an expected 
SD of 15%3 (alpha: 0.05). We considered such difference to 
be well within the physiological meaningful range.3,4,7 For 
secondary outcomes, such as muscle size, muscle strength 
(1RM), and the number of SCs, we estimated our statistical 
power to be 80% to detect a true change of 11%. Statistical 
analyses were performed using IBM SPSS (Statistical Product 
and Service Solutions, version 22, IBM, Chicago, IL, USA) 
and Graph Pad Prism Software (GraphPad Software Inc., La 
Jolla, CA). A linear mixed model was used to assess group 
differences between the failure and non- failure protocol and 
differences from baseline within each group. Group and 
time were included as fixed effects, while subject- ID was in-
cluded as a random effect and baseline values were added as 
a covariate. Sidak posthoc test was used to assess the group 
differences at each time point. Pearson r was used to assess 
correlations. Descriptive data are presented as mean ± SD, 
whereas results are presented as mean with 95% confidence 
intervals. Statistical significance level was set to 5%.
3 |  RESULTS
3.1 | Subjects
One participant dropped out due to circumstances unrelated 
to the study, leaving seventeen participants (age 25 ± 6 years 
old; height 181 ± 12 cm, body mass 80 ± 13 kg, lean body 
mass 64 ± 10, fat 15 ± 6%) who completed all 14 BFRRE 
sessions with both legs.
3.2 | Blood flow– restricted 
resistance exercise
The training load (20% 1RM) of the failure leg (15.1 ± 3.2) 
and non- failure leg (15.1 ± 2.6 kg) remained unchanged dur-
ing the BFRRE intervention. On average, participants per-
formed more repetitions per bout with the failure leg than 
the non- failure leg during training Block1 (84 [95% CI: 71, 
97] vs 70 [67, 73] repetitions, p  =  0.02, respectively) and 
Block2 (95 [82, 108] vs 74 [73, 75] repetitions, p = 0.003) 
(Figure 3A). However, the failure leg only performed more 
repetitions than the non- failure leg in set 1 (Block1: 52 [47, 
58] vs 30, p < 0.001; Block2: 60 [54, 65] vs 30, p < 0.001, 
respectively), whereas the non- failure leg performed more 
repetitions than the failure leg in set three (Block1: 14 [14, 
15] vs 9 [7, 12], p < 0.001; Block2: 15 [15, 15] vs 11 [8, 
14], p  =  0.005, respectively) and four (Block1: 11 [8, 14] 
vs 8 [5, 12], p  =  0.03; Block2: 14 [13, 16] vs 10 [7, 13], 
p = 0.003, respectively). All participants reached the target 
repetitions during the two first sets of BFRRE in the non- 
failure leg. However, several participants failed to complete 
15 repetitions during the fourth set of non- failure BFRRE 
during the first training block (10 and 4 participants in the 
first and seventh BFRRE session, respectively), as well as 
one to three participants during the second block. Total train-
ing volume (repetitions * kg) and repetitions per session 
increased proportionally from training Block1 to Block2 in 
both legs (p < 0.01).
3.3 | Myonuclei and myonuclear domain
The myonuclear data at baseline is presented as the num-
ber of myonuclei per muscle fiber, whereas change values 
are presented as percentage change from baseline. No dif-
ferences were observed between legs in changes of myo-
nuclear number per muscle fiber or myonuclear domain 
(Figure 4, myonuclei: A and B; myonuclear domain: G and 
H). The number of myonuclei in type I fibers increased 
in both legs from baseline (Failure: 2.2 [2.0, 2.4]; Non- 
failure: 2.1 [1.9, 2.3]) to Post10 (Failure: 11.7 [3.6, 19.8]%, 
p  =  0.01; Non- failure: 17.0 [8.9, 25.1]%, p  <  0.01). The 
non- failure leg also increased myonuclear number in type 
I fibers from baseline to the Rest Week (11.1 [4.8, 17.3]%, 
p < 0.01), whereas a tendency was observed in the failure 
leg (7.5 [−1.2, 16.3]%, p = 0.09). The number of myonuclei 
in type II muscle fibers increased from baseline (Failure: 
2.4 [2.2, 2.5]; Non- failure: 2.3 [2.1, 2.5]) to the Rest Week 
(Failure: 13.3 [5.3, 21.3]%; Non- failure: 18.8 [11.6, 26.0]%) 
and Post10 (Failure: 19.9 [11.2, 28.7]%; Non- failure: 22.9 
[16.0, 29.7]%; all p < 0.01).
The number of internally placed nuclei are presented 
as absolute numbers per 50 muscle fibers for both baseline 
and all subsequent time points. The number of internally 
placed nuclei in type I fibers was not significantly different 
between the legs at baseline (Failure: 1.9 [1.5, 2.2], vs non- 
Failure: 2.4 [1.7, 3.0], p = 0.18), but increased more from 
baseline to the Rest Week in the failure leg (3.4 [2.5, 4.3]) 
compared to the non- failure leg (2.6 [2.0, 3.2], p = 0.05). 
With no differences between protocols, the number of in-
ternally placed nuclei in type I fibers further increased to 
the Post10 biopsy (failure leg 3.6 [2.7, 4.4], p  =  0.001) 
and the non- failure leg 3.3 [2.5, 4.1], p  =  0.04). In type 
II muscle fibers, the numbers of internally placed nuclei 
increased in both legs from baseline (Failure: 2.8 [2.3, 3.4]; 
Non- failure: 2.9 [2.3, 3.6]) to the Rest Week (Failure: 4.8 
[4.0, 5.7], p < 0.001; Non- failure: 4.3 [3.3, 5.2], p = 0.03) 
and Post10 (Failure: 4.8 [4.1, 5.4], p < 0.001; Non- failure: 
4.3 [3.4, 5.2], p = 0.01), again with no significant differ-
ences between the protocols.
Muscle fiber area per nucleus (myonuclear domain) de-
creased in type I fibers from baseline (2221 [1988, 2454] 
µm2) to the Rest Week (−11.0 [−18.9, −3.1]%, p < 0.01) and 
Post10 (−18.3 [−26.3, −10.3]%, p < 0.01) in the failure leg, 
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but only from baseline (2319 [2083, 2555] µm2) to Post10 
(−16.8 [−26.0, −7.5]%, p < 0.01) in the non- failure leg. In 
both legs, MFA per nucleus in type II fibers decreased from 
baseline (Failure: 2437 [2101, 2771] um2; Non- failure: 2621 
[2242, 3000] µm2) to Post10 (Failure: −14.8 [−26.3, −3.2]%, 
p = 0.02; Non- failure: −20.1 [−29.7, −10.6]%, p < 0.01), but 
only the non- failure leg decreased significantly to the Rest 
Week (−16.3 [−26.8, 5.9]%, p < 0.01).
3.4 | Satellite cells
No differences between legs were observed in the increases 
of NCAM positive cells (Figure  4C and D). Both the fail-
ure and non- failure leg increased NCAM positive cells 
around type I muscle fibers from baseline (Failure: 4.0 [2.9, 
5.1]; Non- failure: 3.8 [3.1, 4.6], NCAM positive cells per 
100 muscle fibers) to the Rest Week (89.4 [35.7, 143.0]%, 
F I G U R E  4  Immunohistochemistry. 
Myonuclei number per muscle fiber type 
I (A) and II (B). NCAM+ myogenic stem 
cells per muscle fiber type I (C) and II (D). 
Muscle fiber cross- sectional area, type I 
(E) and type II (F). Muscle fiber cross- 
sectional area (MFA) per nucleus, type I (G) 
and II (H). The relative changes are from 
baseline to after the first block of training 
(Rest Week) and 10 days after cessation 
of training (Post10). * represents p < 0.05. 
Data are expressed as means with 95% 
confidence intervals
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p = 0.01, and 95.4 [35.4, 155.4]%, p = 0.01, respectively) 
and Post10 (100.9 [28.1, 173.7]%, p = 0.01, and 91.9 [30.1, 
153.6]%, p = 0.01, respectively). Similarly, NCAM positive 
cells around type II muscle fibers increased from baseline 
(Failure: 4.8 [3.3, 6.3]; Non- failure: 4.7 [3.3, 6.1]) to the Rest 
Week (Failure: 46.2 [5.6, 86.8]%, p  =  0.03; Non- failure: 
56.4 [4.4, 108.3]%, p = 0.04) and Post10 (Failure: 39.0 [9.8, 
68.2]%, p = 0.02; Non- failure: 49.0 [0.9, 97.0]%, p = 0.05) 
in both legs.
3.5 | Muscle fiber cross- sectional areas
No differences between legs were observed in MFA changes. 
However, type I MFA decreased from baseline (Failure: 
4680 [4337, 5022] µm2; Non- failure: 4727 [4255, 5199] µm2) 
to Post10 in the failure leg (−10.3 [−18.5, −2.1]%, p = 0.03), 
while no change was observed in the non- failure leg (−0.8 
[−13.0, −13.8]%, p > 0.05). (Figure 4E and F). The type II 
MFA did not change from baseline (Failure: 5092 [4926, 
6344] µm2; Non- failure: 5979 [5187, 6772] µm2) to Post10 in 
either leg (Failure: 0.2 [−11.1, −11.4]%, Non- failure: −2.6 
[−14.2, −11.5]%, p  >  0.05). A histogram of muscle fiber 
sizes is presented in Figure 5.
3.6 | Fiber type distribution
The percentage distribution between the type I and type 
II fibers for the failure leg was 39/61 at baseline, 40/60 
at 2 hours after the first session, 38/62 at Rest week, and 
39/61 at Post10. The percentage distribution between the 
type I and type II fibers for the non- failure leg was 40/60 
at baseline, 40/60 at 2  hours after the first session, 39/61 
at Rest week, and 38/62 at Post10. No significant changes 
were observed in the fiber type distribution. However, in 
a few of the images used for fiber type and area analyses, 
some clusters of small diameter myofibers were apparent 
in samples from the Rest Week and also from Post10 dis-
played only weak SC- 71c staining (1– 2 subjects each for 
the failure and the non- failure leg for each of these time 
points). Given that type IIA and type IIX fibers show strong 
F I G U R E  5  Histogram of muscle fiber size. Frequency of muscle fiber areas in type I muscle fibers of the Failure leg (A), type I muscle fibers 
of the Non- failure leg (B), type II muscle fibers of the Failure leg (C), and type II muscle fibers of the Non- failure leg (D). Black bars denote 
baseline muscle fiber areas, green denote Rest Week data, and purple denote Post10 data [Colour figure can be viewed at wileyonlinelibrary.com]
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and moderate staining, respectively, while type I fibers do 
not stain positively for SC- 71,14,18 these small fibers were 
excluded from MFA analyses because they could not be 
identified with certainty as either type I or II myofibers. 
Interestingly, the same small fibers were typically strongly 
positive for NCAM on nearby sections, and these fibers 
were often found in the periphery of the fascicles. These 
observations prompted us to take new images covering the 
whole sections in order to search specifically for NCAM- 
positive muscle fibers.
3.7 | NCAM- positive muscle fibers
In the muscle samples from the Rest Week, clusters or 
groupings of strongly NCAM- positive muscle fibers were 
observed in seven subjects in the failure leg, and in four 
subjects in the non- failure leg. In two subjects, clusters 
were found in samples from both legs. In the samples from 
the Post10, clusters of strongly NCAM- positive muscle 
fibers were observed in one subject in the failure leg, and 
in two subjects in the non- failure leg. The percentage of 
NCAM- positive fibers in these subjects ranged between 
1% and 25%, with the exception of one individual who 
displayed ~50% positive fibers in the failure leg at Rest 
Week. No small or large groupings of strongly NCAM- 
positive fibers were observed in any subject in the Pre and 
2 hours samples. Two representative examples of clusters 
of NCAM- positive muscle fibers are shown in Figure 6. A 
more detailed analysis of the nature and extent of these fib-
ers is planned for a separate publication.
3.8 | Whole muscle size
No differences in CSA or muscle thickness were observed 
between the failure and non- failure leg at any time- point or 
over the time course of the study (Figure 7). The CSA of RF 
(Failure: 7.3 [6.2, 8.4] cm2; Non- failure: 6.7 [5.7, 7.6] cm2, at 
baseline), thickness of RF and VL (Failure: RF, 18.6 [16.8, 
20.5] mm and VL, 25.6 [23.8, 27.5] mm; Non- failure: RF, 
18.0 [16.5, 19.6] mm and VL, 25.5 [23.6, 27.3] mm, at base-
line) and thickness of VI (Failure: 17.2 [14.7, 19.6] mm; 
Non- failure: 17.7 [15.5, 19.9] mm, at baseline) all showed 
a biphasic pattern with significant increases during the two 
training blocks (4%– 13%) and transient reductions in the Rest 
Week in the failure and non- failure leg. After the last training 
block, muscle CSA and thickness stabilized at a level 4%– 
10% above baseline levels for RF and VL (all p < 0.01), but 
thickness of VI was not significantly different from baseline 
at the post- training measurements, except for a 4% gain in the 
failure leg at Post3 (p < 0.05). The gains in muscle thickness 
were greater in RF than VI in both legs at all post- training 
time points (p  =  0.001– 0.03). Muscle thickness of RF also 
increased more than that of VL in both legs at Post3 to Post24 
(p = 0.01– 0.05), except for the failure leg at Post10 (p = 0.14) 
and the non- failure leg at Post24 (p = 0.14). VL muscle thick-
ness increased more than VI in the non- failure leg at Post3 
(p = 0.03) and also tended to increase more than VI in the 
same leg at Post17 (p = 0.06). In addition, the gain in muscle 
thickness tended to be greater in VL than in VI in the failure 
leg at Post24 (p = 0.10). Increases in CSA of RF correlated 
with the increases in muscle thickness of RF (eg, Failure: 
r = 0.68, Non- failure: r = 0.67, both p < 0.05, at Post24).
F I G U R E  6  Representative examples of 
areas with strongly NCAM + regenerating 
muscle fibers. The images were slightly 
overexposed to highlight the thicker basal 
lamina in the NCAM + fibers. Laminin 
staining in red and NCAM staining in 
green [Colour figure can be viewed at 
wileyonlinelibrary.com]
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3.9 | Echo intensity
Changes in echo intensities of VL and RF are presented in 
Figure 7E and F. VL echo intensity increased in both legs 
from baseline (Failure: 47.2 [40.5, 53.9] arbitrary units [AU]; 
Non- failure: 44.9 [40.3, 49.5] AU) to Day3 (~13%) and Day5 
(~20%) during Block1 (p < 0.001). However, echo intensity 
of VL normalized after the Rest Week only in the non- failure 
leg (Day15: Failure: 8.0% vs Non- failure: 1.2%, p = 0.003). 
VL echo intensity of the failure leg tended to increase more 
than the non- failure leg during Block2 (Failure: 11%– 14% vs 
Non- failure: 5%– 7%, p = 0.08), and was significantly higher 
than in the non- failure leg at Post3 (Failure: 7.1% vs Non- 
failure: 0.4%, p = 0.04) and at Post10 (Failure: 4.1% vs Non- 
failure: −3.7%, p = 0.03). At Post17, echo intensity of VL 
was decreased compared with baseline in the non- failure leg 
(p = 0.04) and tended to decrease in the failure leg (p = 0.07), 
with no differences between legs (−6% to 7% in both). At 
Post24, echo intensity was significantly decreased in both 
legs compared with baseline (−11% to 10%, p ≤ 0.002).
RF echo intensity was increased after both protocols from 
baseline (Failure: 53.3 [47.4, 59.2] AU; Non- failure: 52.8 
[48.8, 56.9] AU) to Day3 (11%– 14%) and Day5 (19%– 20%) 
during the first block of BFRRE (p ≤ 0.001), but was normal-
ized after the Rest Week only in the non- failure leg (Day15: 
Failure: 7.6% vs Non- failure: 1.9%, p = 0.03). The failure leg 
tended to increase more in echo intensity than the non- failure 
leg during the second block of BFRRE (Failure: 11%– 14% 
vs Non- failure: 6%– 7%, p = 0.06). Echo intensity was also 
increased more in the failure leg at Post3 (Failure: 7.5% vs 
F I G U R E  7  Muscle cross sectional area, thickness and echo intensity. Relative increases in the (A) cross- sectional area (CSA) of m. rectus 
femoris (RF) and muscle thickness of (B) RF, (C) m. vastus lateralis (VL) and (D) m.vastus intermedius, as well as echo intensity of (E) RF and (F) 
VL, expressed on a timeline from the first day of BFRRE until the last measurements at day 43. * represents significant differences between legs 
(p < 0.05), # represents significant within- leg changes compared to baseline (p < 0.05). Data are expressed as means with 95% confidence intervals
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Non- failure: 1.5%, p  =  0.02) and tended to increase more 
at Post10 (Failure: 5.9% vs Non- failure: 0.1%, p  =  0.09). 
With no differences between legs, echo intensity of RF was 
decreased after both protocols at Post17 (~7%) and Post24 
(~9%, both p < 0.05).
Increases in echo intensity were correlated with the in-
creases in CSA of RF and thickness of VL during Block1 
(summed average of Day3 and Day5) in the failure leg 
(r = 0.40 and r = 0.71, respectively) and the non- failure leg 
(r = 0.44 and r = 0.69, all p < 0.05).
3.10 | Muscle strength
At baseline, the two measures of knee extension strength 
(MVC and 1RM) were very similar between the two legs 
(MVC: Failure: 224 [203, 244] Nm; Non- failure: 224 
[204, 244] Nm. 1RM: Failure: 74.8 kg [66.8, 82.7]; Non- 
failure: 73.2 kg [66.4, 79.9]). No differences were observed 
between the failure and non- failure leg in 1RM or MVC 
over the entire time course of the study, except for Post3, 
where the failure leg displayed greater reductions in MVC 
than the non- failure leg (−8% vs −4%, p  =  0.03, respec-
tively, Figure 8A). Only the failure leg reduced MVC from 
baseline to the first day of Block2 and to Post10 (~−5%, 
p < 0.05). Both legs showed decreases in MVC from base-
line to the Rest Week (−8% to 10%, p < 0.01). After Post3, 
MVC showed an overall upward trend and at Post24 MVC 
was increased in both legs compared to pre- training values 
(~7%, p = 0.01).
Maximal isometric contraction of both legs was reduced 
2  hours after the first BFRRE session of Block1 (−14% 
to 17%, p < 0.001) and Block2 (−7% to 12%, p < 0.001), 
with no differences between legs. The decrease in MVC was 
larger 2  hours after the first BFRRE bout of Block1 com-
pared to Block2 in the non- failure leg (p = 0.01), and tended 
to be greater in Block1 versus Block2 also in the failure leg 
(p = 0.09).
The failure leg decreased in 1RM from baseline to the Rest 
Week compared to the Non- failure leg (−5.2% [−9.1, −1.4] 
vs −0.9% [−5.2, 3.4], p = 0.03, respectively), but both legs 
increased 1RM from baseline to Post17 (7%– 8%, p < 0.01) 
and Post24 (9%– 11%, p < 0.01, Figure 8B).
3.11 | Delayed- onset muscle soreness, 
perceived exertion, and – pain
Changes in DOMS, perceived exertion and - pain are pre-
sented in Figure  3B– D. On average, participants reported 
higher DOMS in the failure leg than in the submaximal leg 
during Block1 (Failure: 32 [21, 43] mm vs Non- failure: 27 
[17, 37] mm, p = 0.01) and Block2 (Failure: 24 [15, 34] mm 
vs Non- failure: 19 [10, 27] mm, p < 0.01). Reported DOMS 
levels were significantly higher in Block1 versus Block2 
in both the failure leg (p  =  0.05) and the non- failure leg 
(p < 0.01).
Perceived pain data are presented as Borg CR10 score 
(range 0– 10). Participants reported lower perceived pain 
in the non- failure leg during Block2 (Failure: 6.6 [5.9, 
7.2] vs Non- failure: 5.1 [4.1, 6.1], p  =  0.04) and tended 
to report lower pain ratings in the non- failure leg also in 
Block1 (Failure: 7.7 [7.0, 8.3] vs Non- failure: 6.4 [5.6, 7.3], 
p  =  0.06). Similarly, perceived exertion was consistently 
lower in the non- failure leg during both training periods 
(Block1, Failure: 18.5 [18.1, 18.9] vs Non- failure: 16.4 
F I G U R E  8  Maximal strength. Relative change in (A) maximal voluntary isometric contraction (MVC) and (B) 1- repetition maximum during 
the Rest Week, first day of Block2 (only MVC), as well as 3- (Post3), 10- (Post10), 17- (Post17), and 24 days (Post24) after cessation of training, 
* represents significant differences between legs (p < 0.05), # represents significant within- leg changes compared to baseline (p < 0.05). Data are 
expressed as means with 95% confidence intervals
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[15.5, 17.2], p < 0.001; Block2, Failure: 17.7 [17.0, 18.4] 
vs Non- failure: 14.5 [13.2, 15.8], p < 0.001). Perceived pain 
and - exertion levels were significantly higher in Block1 ver-
sus Block2 in both the failure leg (p ≤ 0.001) and the non- 
failure leg (p < 0.001).
3.12 | Myoelectric activity during BFRRE
Electromyography amplitudes in VL and RF during the 
first BFRRE bout of Block1 and Block2 are presented in 
Figure 9. VL RMS was higher in the failure leg compared 
to the non- failure leg during set 1 in the last three repetitions 
(Block1, p = 0.001; Block2, p < 0.001) and middle repeti-
tions (Block1, p = 0.05; Block2, p = 0.03). VL RMS was 
also higher in the failure leg compared to the non- failure leg 
during set 2 in the first three (Block1, p = 0.006; Block2, 
p < 0.001), middle (Block1, p = 0.008; Block2, p < 0.001) 
and last three repetitions (Block2: p  <  0.001; tendency in 
Block1, p = 0.08), as well as during set 3 in the first three 
(Block1, p  =  0.03; Block2: p  <  0.001) and middle repeti-
tions (Block1, p = 0.05; Block2, p = 0.02). No differences 
between legs were observed in VL RMS in the first three rep-
etitions in set 1 and in set 4 (besides the three first repetitions 
during Block2: p = 0.01).
RF RMS was higher in the failure leg than the non- failure 
leg in the last three (Block1, p = 0.007; Block2, p = 0.03) and 
middle (only in Block1: p = 0.003) repetitions during set 1, in 
the first (Block1, p = 0.001; Block2, p = 0.004), and middle 
(Block1, p = 0.03; Block2, p = 0.04) repetitions during set 
2, and the first three (Block1, p = 0.02; Block2, p = 0.05) 
during set 3. No differences between legs were observed in 
RF RMS for the first three repetitions in set 1, and in set 4, 
respectively.
3.13 | Creatine kinase and myoglobin
Creatine kinase (Figure  10) increased from 168  ±  130 
U/L (mean ± SD) at baseline to 190 ± 117 U/L 2 hours 
post BFRRE (p = 0.006), to 218 ± 115 U/L 4 hours post 
BFRRE (p  <  0.001), and to 407  ±  312 U/L on Day4 
(p  =  0.04). Three individuals increased CK from ~150 
UL at baseline to 800– 1250 UL at Day4, the remaining 14 
participants increased with less than 400 UL from base-
line to Day4.
Myoglobin increased from 34  ±  24  µg/L at base-
line to 69 ± 35 µg/L (p < 0.001) 2 hours post BFRRE, to 
86  ±  53  µg/L (p  =  0.01) 4  hours post- BFRRE, and to 
52 ± 35 µg/L (p = 0.04) at Day4.
F I G U R E  9  Myoelectric activity during BFRRE. Myoelectric activity of m. vastus lateralis (VL) and m. rectus femoris (RF) during the 
three first, middle, and last repetitions in each of the four sets of BFRRE at the first (Figure 9A in VL and - B in RF) and second training blocks 
(Figure 9C in VL and - D in RF). * represents significant differences between legs (p < 0.05). Data are expressed as means with 95% confidence 
intervals. RMS, root mean square [Colour figure can be viewed at wileyonlinelibrary.com]
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4 |  DISCUSSION
There were several notable findings in the present study. 
First, we demonstrate that both non- failure and failure high- 
frequency BFRRE can induce marked early increases in 
SCs, with no differences between protocols. Second, we cor-
roborate and extend our previous finding that the increase in 
the number of myonuclei may occur gradually as opposed 
to only early in the time- course with both a non- failure and 
failure protocol during short- term frequent BFRRE. Third, 
echo intensity of VL and RF was increased over baseline in 
both legs during the first block of BFRRE (~20%), but de-
creased during the Rest Week and was generally lower in 
the non- failure than in the failure leg during and after the 
second training block. Interestingly, however, echo intensity 
was lower than baseline in both legs at 17 (~7%) and 24 days 
(~11%) post- training. Finally, we demonstrate that both 
non- failure and failure protocols decreased muscle strength 
after the first week of strenuous high- frequency BFRRE, but 
more so after the failure protocol, followed by a very late 
supercompensation in strength ≥3 weeks after the last train-
ing session. Collectively, these findings indicate a temporary 
overtraining effect after both BFRRE protocols, especially 
during the first block of BFRRE.
4.1 | Training data
The knee extension exercise was used by Nielsen et al.7 and 
by us at the same relative intensity (20% of 1RM). However, 
the range of repetitions differed between our respective studies. 
The participants in Nielsen et al.7,19 performed only 45 repeti-
tions per session in the first three days and on average ~52 rep-
etitions in total per session during the first week, whereas the 
training volume in the present study and in our previous4 was 
similar, around 80– 84 repetitions per session during the first 
week in the legs that trained to failure in all sets. In the non- 
failure leg of the present study, the mean total training volume 
increased from 67 to 74 repetitions during Block1. Even these 
latter figures are considerably higher than the ~52 repetitions 
reported by Nielsen et al.7,19 As discussed previously,4 these 
discrepancies may be due to differences in cadence and possi-
bly also in load, and probably also due to that we “pushed” our 
participants harder before they reached the criteria of voluntary 
failure.
4.2 | Satellite cell and myonuclear responses
The increases in the number of SCs (type I fibers: ~90% to 
100%; type II fibers: ~45% to 55%) and myonuclei (~20%) dur-
ing the short- term BFRRE in both the failure and non- failure 
leg were of similar or even greater magnitudes compared to 
responses seen previously in young men after longer periods 
(eg, 16  weeks) of heavy- load strength training (SCs: 30%– 
50%, and myonuclei number: ~20%).20,21 However, in contrast 
to the BFRRE study of Nielsen et al.,7 myofiber areas did not 
increase after the first block in the present study, and both our 
protocols induced merely one- fourth of the increases in SC 
numbers reported by Nielsen et al.7 Moreover, while the peak 
increases in myonuclear number differed slightly in the present 
study compared to Nielsen et al.7 and Bjørnsen et al.4 (~20% 
vs 30% and 30%, respectively), the time courses of responses 
were very different. In Nielsen et al.,7 the myonuclei and SC 
numbers peaked after the first week and SCs were then de-
creased from these peak values 10 days after the intervention, 
whereas we in the present study and in Bjørnsen et al.4 ob-
served gradual increases and peak values 10 days after the last 
training session. It could be speculated that this delayed peak 
in SCs was at least in part related to a regeneration process, 
F I G U R E  1 0  Creatine kinase and myoglobin. Increases in the 
(A) myoglobin and (B) creatine kinase levels at baseline, 2- and 
4 h after the first BFRRE session, as well as at rest the fourth day 
of BFRRE. Dotted lines denote individual responses. * represents 
significant differences from baseline (p < 0.05). Data are expressed as 
means with 95% confidence intervals [Colour figure can be viewed at 
wileyonlinelibrary.com]
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as previously observed after exercise- induced muscle damage 
(eg, [22]). In support of this hypothesis, we observed marked 
increases in internally located nuclei (95%– 160%) in both fiber 
types, but more so in type I fibers of the failure leg after the 
first training block. Nuclei with an internal myofiber position 
are strongly associated with tissue regeneration in skeletal 
muscle.15 Further evidence for some type of degeneration– 
regeneration response, such as NCAM- positive fibers, is dis-
cussed below.
Nevertheless, our finding in the present study of increased 
numbers of myonuclei in both type I and type II fibers after 
just seven sessions of BFRRE is in agreement with that of 
Nielsen et al,7 and thus corroborates that myonuclear addi-
tion can occur already within 8– 10 days of high- frequency 
BFRRE.
4.3 | Changes in whole muscle size and echo 
intensity during high- frequency BFRRE
Muscle CSA in the RF as well as muscle thickness in the 
VL and RF increased gradually during the training blocks 
and were elevated by 6%– 10% after the BFRRE interven-
tion, whereas the increase for VI was non- significant (~2%). 
Interestingly, the increases in echo intensity in the current 
study were prolonged especially in the failure leg, lasting for 
at least 10 days after both training blocks, but the non- failure 
leg also displayed prolonged (~3 to 10  days) elevations in 
echogenicity.
Normal muscle has a low echo intensity and is, there-
fore, relatively black on ultrasound pictures. The speckled 
appearance of muscle in pictures taken in the transverse 
plane is caused by reflections of perimysial connective tissue, 
which is moderately echogenic.23 Notably, isotonic saline in-
jection into muscle causes immediate increases in echo inten-
sity,24 which strongly suggests that fluid accumulation in the 
perimysial space (ie, between fascicles) is sufficient to cause 
increases in echogenicity. In addition, changes in connective 
tissue and/or adipose tissue can also increase muscle echo 
intensity,24 and increased amounts of interstitial fibrous tis-
sue are strongly correlated with elevations in echo intensity.11
The ~20% increases in echo intensity that we observed on 
Day5 in the first training block in both legs, together with the 
prolonged elevations, are thus probably indicative of some 
type of muscle damage and/or remodeling, and this notion is 
further supported by the fact that increases of this magnitude 
have been reported 2– 5 days after acute maximal eccentric 
exercise.25 We, therefore, suggest that the most plausible ex-
planation for our results on echo intensity is prolonged re-
modeling of the extracellular matrix (ECM) and associated 
swelling of the perimysium and other interstitial spaces, re-
lated to muscle damage and/or stress and inflammation. In 
support of this suggestion, the strongly NCAM- positive fi-
bers encountered in the samples from the Rest Week almost 
invariably displayed thickened laminin staining (Figure  6), 
thus providing direct evidence of extracellular matrix re-
modeling in these areas. In addition, the interstitial spaces 
were visibly increased, especially in the most damaged areas, 
in which there was apparent severe myofiber damage and/
or atrophy and possibly even loss of some muscle fibers 
(Figure  11). Finally, we observed increased immunostain-
ing of markers of ECM remodeling as well as muscle fibers 
F I G U R E  1 1  Examples of areas with 
more severe degeneration– regeneration, and 
examples of markedly increased interstitial 
spaces. Images from two of the subjects 
who displayed areas with more severe 
degeneration– regeneration, and examples of 
markedly increased interstitial spaces. The 
images were overexposed to highlight the 
NCAM + fibers and the increased interstitial 
spaces [Colour figure can be viewed at 
wileyonlinelibrary.com]
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positive for other regeneration markers in addition to NCAM 
in muscle samples obtained at Rest Week and Post10 (un-
published data). The delayed peak in SCs could also in part 
be related to a potential remodeling of the extracellular ma-
trix (eg, [26]). It should be noted that the muscle biopsies 
obtained in the Rest Week were taken 5 days after the last 
session in Week 1 of training, and that the echo intensity was 
elevated by ~20% in the VL in both legs just before the last 
two sessions in Week 1, as compared to the ~10% increase at 
Rest Week in the failure leg. Therefore, we probably did not 
capture the peak extent of ECM remodeling and interstitial 
edema in our muscle samples even in the failure leg.
Previous studies investigating the effects of high- 
frequency (twice daily) low- load BFRRE on increases in 
whole muscle size27,28 have observed increases in quadri-
ceps muscle CSA of 3.5% and 8% with one and two weeks 
training, respectively, corresponding to 0.5%– 0.6% in CSA 
per calendar day. In the present investigation, the rates were 
somewhat lower, about 0.3%– 0.5% in muscle thickness per 
day in VL and RF, and only about 0.1% per day in the VI. 
Our estimates are based on Post3, when echo intensity had 
essentially returned to baseline levels in the non- failure leg. 
It is possible that there were less muscle damage or stress- 
related remodeling in the studies by Fujita et al.27 and Abe 
et al.,28 which combined with a higher training frequency (12 
sessions per week) in turn may have enabled an earlier and 
faster hypertrophic response.
However, it should be noted that neither of these studies in-
cluded any assessments of sub- acute signal changes (eg, T2 re-
laxation times), and the post- training MRI measurements were 
performed at 48 hours after the last training session. Interestingly, 
Nielsen et al.7 observed marked but transient increases (~27%) 
in myofiber areas in the group which performed low- load train-
ing without BFR, and suggested that early increases in MFA 
in the BFRRE group were similarly driven in part by transient 
swelling, as observed acutely after low- load BFRRE (eg,[29]). 
Therefore, it cannot be ruled out that some of the rapid gains 
in muscle CSA in the studies of Abe et al.28 and Fujita et al.27 
consisted of interstitial and/or intracellular swelling, in addition 
to increased contractile protein content. This is also indicated 
by the data on estimated thigh muscle- bone area in Abe et al.,28 
which revealed a nearly 8% increase in just the first 6 days of 
training, but a subsequent ~2% loss during the 2 days of rest 
between the first and second training weeks.
In the present study, the increases in muscle thickness of 
RF and VL during the first block were correlated with the in-
creases in echo intensity (r ~ 0.42 and r ~ 0.70, respectively) 
in both legs, and RF CSA and VI thickness decreased by 
~5% and 7% in the 5 days between the last BFRRE session in 
Block1 and Day10 in the Rest Week. These findings strongly 
indicate that the increases in muscle size during the training 
blocks were in part driven by edema. Nevertheless, it is worth 
noting that the RF in the non- failure leg gained a further ~6% 
in CSA over baseline from Day15 to Day22 (Post3), while 
echo intensity was almost unchanged from pre- training at the 
same time points. This suggests the possibility that a rapid 
hypertrophic response took place in the RF with Block2 in 
the non- failure leg, which is further supported by the rela-
tively stable RF CSA from Post3 to Post24, although echo 
intensity decreased below baseline during the same period, 
as discussed below.
In sharp contrast, the VI muscle thickness decreased with 
a remarkable ~6% to 7% in both legs in just 3– 5 days after both 
Block1 and Block2. It is of note that the VI appears to be the 
most active muscle in knee extension exercise at low loads.30 
We, therefore, suggest that the VI is overall the most stressed 
muscle with low- load BFR knee extensions. Unfortunately, 
we were unable to reliably assess echo intensity for the VI, 
because the ultrasound settings were optimized for the RF in 
the same pictures. Nevertheless, excessive stress of the VI 
would explain why this muscle showed both the most drastic 
decreases in muscle thickness during the Rest Week and the 
least hypertrophy post- training of the investigated muscles.
Most notably, while muscle thickness in the RF and VL 
and CSA in the RF did not change significantly between Post3 
and Post24, there were marked decreases in echo intensity 
during the same period, ending up at ~10% below the base-
line values in both legs and both RF and VL. Muscle echo 
intensity is increasingly used as a marker of muscle quality23 
and has been found to be inversely correlated with strength 
and power.31 Furthermore, some studies have reported de-
creases in echo intensity after a period of strength training 
in both untrained32 and trained participants.12 Thus, the de-
creases in echo intensity of the present study concomitant 
with the delayed increases in strength occurring between 10 
and 24 days after BFRRE indicate the intriguing possibility 
that remodeling was still going between these time points. A 
decreased echo intensity may have been caused by decreased 
perimysial spaces. The possibility of decreased interstitial 
spaces and thus increased packing of muscle fibers and fasci-
cles has been suggested by Goldspink.33
4.4 | Changes in muscle fiber size during 
high- frequency BFRRE
In contrast to muscle thickness in m. vastus lateralis, the 
MFA did not increase and was even reduced in type I fibers 
of the failure leg at 10 days after the intervention in the pre-
sent study. In further support of some type of degeneration– 
regeneration response, we observed small diameter myofibers 
that were strongly positive for NCAM in several biopsies ob-
tained during the Rest Week and to a somewhat lesser extent 
also at Post10 (unpublished data).
The discrepancy between changes in MFA versus the 
increase in whole muscle CSA and - thickness is intriguing. 
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At least in part, this may be due to muscle fiber atrophy 
and/or some type of degeneration– regeneration induced 
by the very strenuous training regime. NCAM is mark-
edly upregulated in regenerating human muscle fibers but 
purportedly not in necrotic or degenerating fibers.34 On 
nearby sections, these fibers displayed for the most part 
intact but weak dystrophin staining. We therefore interpret 
these fibers as undergoing regeneration after some type 
of damage and/or stress and we are currently investigat-
ing the nature and the numbers of these NCAM +  fibers 
in more detail, including other markers for degeneration– 
regeneration processes (unpublished data). We observed 
an increased interstitial space in some of our participants 
around the small NCAM- positive fibers (Figure  11). As 
discussed previously, we propose that an enlarged inter-
stitial space occurred, presumably caused by extracellular 
swelling and remodeling of the extracellular matrix, and 
that this would in part explain both the increased echo in-
tensity and the discrepancy between myofiber and whole 
muscle changes. Furthermore, given the results of our pre-
vious BFRRE study which showed late increases in myofi-
ber areas,4 it seems reasonable to speculate that the muscle 
fibers eventually recovered and perhaps even increased in 
size at Post17 and Post24. It also deserves to be noted that 
fiber hypertrophy and whole muscle hypertrophy can differ 
rather substantially after periods of resistance training, and 
that muscle fibers from a single level of a muscle are not 
necessarily representative of the whole muscle. For discus-
sion and references, the reader is referred to Lexell et al.35 
and D’Antona et al.36
In contrast to our previous study,4 we could not detect any 
significant type II fiber atrophy in this investigation, despite 
very similar training protocols and overall training volumes. 
On the other hand, we found a decrease in type I fiber areas 
which persisted at Post10 in the failure leg, in contrast to the 
18% increase in type I fiber area at Post10 that we reported 
in our previous study. These discrepancies are puzzling and 
warrant some discussion.
In our previous study,4 the subjects were generally bet-
ter trained at the start of the training intervention than the 
subjects in this study. Another difference from our previous 
investigation is that the subjects in this study received 20 g 
of whey protein after every training session. Interestingly, 
Farup et al37 showed that 20 g of whey protein preferen-
tially enhanced type II fiber hypertrophy after concentric 
resistance training. It is thus possible that there was a sim-
ilar preferential effect on type II fibers in this study, that 
is, the whey protein supplement largely protected type II 
fibers but not type I fibers from atrophy due to excessive 
stress. Another possibility, not mutually exclusive to those 
above, is that branching and perhaps also new fiber forma-
tion may be a regenerative response to severe stress which 
could serve to decrease the diffusion distance for oxygen 
in the muscle fibers (for further discussion, refer Nygaard 
& Nielsen38). If the branching and new fiber formation is 
extensive enough, the whole muscle may hypertrophy even 
though the mean fiber area would seem to decrease, and 
branching might allow for cell survival until the microcir-
culation has adapted sufficiently to the imposed exercise- 
induced ischemia.
Regardless, the increases in internally located nuclei, the 
small muscle fibers strongly positive for NCAM in some of 
the subjects, and the increased echo intensity are all consis-
tent with the proposal that some type of regeneration and re-
modeling was still ongoing as late as 10 days after the last 
BFRRE session in the failure leg.
4.5 | Changes in strength during high- 
frequency BFRRE
As already noted, the changes in strength were seemingly in-
versely paralleled by the changes observed in muscle echo 
intensity. This relationship was particularly striking between 
Post3 and Post24 in the failure leg, during which time the echo 
intensity in both RF and VL decreased markedly while MVC 
and 1RM increased, and the CSA and thickness in these mus-
cles stayed elevated at an almost constant level. Interestingly, 
Nielsen et al19 did not observe increases in isokinetic strength 
at slow velocity until 12 days after BFRRE, whereas fast ve-
locity strength decreased at 5 days post- training, further sup-
porting a delayed effect on force- generating capacity after 
high- frequency strenuous BFRRE. Very delayed strength 
increases have previously been observed after 4  weeks of 
detraining during high- frequency electrical stimulation.8 
However, to the best of our knowledge, we are the first to 
observe a delayed supercompensation in strength occurring 
as long as 24 days after BFRRE. The very late increases in 
strength observed with BFRRE in the present study may be 
explained by the prolonged time course of the physiological 
adaptations taking place at the muscle fiber level and/or in 
the surrounding extracellular matrix.
4.6 | Possible role of muscle damage in 
delayed effects of high- frequency BFRRE
It has been suggested that performing low- load BFRRE 
causes little or no muscle damage.39 However, several re-
cent studies have shown that performing acute high- volume 
BFRRE to voluntary failure can increase markers of muscle 
damage and cellular stress.5,34,40– 43 In line with this, we re-
cently observed increases in markers of muscle damage with 
an initial block of frequent low- load BFRRE to voluntary 
failure.4 The prolonged reductions and subsequent delayed 
increases in strength, as well as the DOMS, elevated levels of 
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CK and myoglobin, decreased type I fiber areas and marked 
increases in muscle echogenicity in the present study are also 
in line with some degree of muscle damage and stress.
An important point when comparing our results to previ-
ous studies on frequent low- load BFRRE concerns the pro-
gression of the training during the first sessions. For example, 
Abe et al.28 gradually increased the BFR pressure during the 
first 10  days of training. Similarly, and as noted earlier, the 
participants in the investigation of Nielsen et al.7,19 performed 
only 45 repetitions per session in the first three training bouts. 
In contrast, the present study involved BFRRE to failure in 
one leg and near- maximal efforts also in the non- failure leg 
BFRRE in the early stages of training, as several participants 
failed to complete the target repetitions in the non- failure leg in 
the first three BFRRE bouts. The EMG results generally sup-
port high levels of muscle activation also in the non- failure leg 
in the last 1– 2 sets. Thus, a gradual familiarization to BFRRE 
may be necessary to protect against excessive and potentially 
counterproductive muscular stress at the initiation of training, 
which in turn could explain many of the discrepancies between 
our findings and those of Nielsen et al.7
Finally, the attenuated responses in echo intensity, 
DOMS, and perceived pain, as well as in acute decrements in 
force with the second block compared with the first block of 
BFRRE, are in line with the repeated- bout effect after strenu-
ous acute BFRRE reported by Sieljacks et al,5 which support 
a repeated bout effect reminiscent that seen after damaging 
eccentric exercise.5
4.7 | Strengths of the study
We employed strength tests that were both standardized and 
designed to minimize any “learning effects”, thus allowing 
valid assessments of quadriceps muscle function. In parallel 
with these, we investigated the trophic state and adaptations 
of the muscles at both cellular and whole muscle levels and 
at many time points, particularly with reference to the post- 
training period. Collectively, our results may have important 
implications for the interpretations and the choice of time 
points of muscle size and strength measurements not only 
after BFRRE but also with conventional heavy resistance 
exercise. Our findings may also shed light on some of the 
mechanisms involved in the phenomena of exercise- induced 
overreaching and recovery and subsequent improvements of 
performance.
4.8 | Limitations
First of all, several participants did not reach the repetition 
goal in the non- failure leg in the first few sessions of Block1; 
hence, some sets were performed to volitional failure also in 
the non- failure leg. Second, we used an identical absolute cuff 
pressure across all participants. However, the same cuff pres-
sures were always applied to both the failure and non- failure 
leg of each participant. Furthermore, based on the small varia-
tions in arterial occlusion pressure (AOP) in our recent study,4 
we argue that we achieved reasonably similar degrees of BFR 
in our subjects. Third, while within- subject designs have sev-
eral advantages,44 positive cross- transfer effects of lower- 
body BFRRE on the trophic state of upper limb muscles 
trained with low loads but without BFR have been reported.45 
A positive cross- transfer effect could potentially cause more 
uniform results between the failure versus non- failure train-
ing protocols. Conversely, other investigations have observed 
detrimental effects of strenuous unilateral exercise on the 
muscles of the resting contralateral limb (eg, [46]). Thus, we 
cannot exclude possible “cross- transfer” effects, both positive 
and negative, from the failure leg to the non- failure leg (and 
vice versa). In addition, the failure versus non failure protocol 
was randomized between the right and left leg, but having a 
fixed order of left and right leg during exercise and testing 
could still have induced systemic bias on capacity for voli-
tional central neural activation between the two legs. Finally, 
our counting criteria for NCAM positive staining seems to be 
more restrictive than what is commonly used, causing the av-
erage number of SCs per muscle fiber at baseline to be lower 
in the present study compared to the majority of reports (~0.05 
at in the present study versus ~0.10 in eg, [7, 13, 20]). This 
may have reduced the sensitivity of our SC analysis.
In conclusion, we report that both a non- failure and fail-
ure high- frequency short- term BFRRE protocol induced 
pronounced responses in SC proliferation, but delayed 
myonuclear addition and increases in whole muscle size, 
concomitantly with very delayed increases in strength. The 
initial strength decrements followed by delayed hypertrophy 
and strength increases are reminiscent of the supercompensa-
tion observed after periods of resistance exercise “overreach-
ing”.8,9 While the gains in SC and myonuclear numbers as 
well as muscle size and strength were similar between the 
legs, perceptions of exertion, pain, and DOMS were lower 
in the non- failure leg. Hence, non- failure BFRRE may be a 
more feasible approach.
4.9 | Perspectives
It seems that very strenuous protocols with a high overall 
training volume can be counterproductive at least in the ini-
tial stages with high- frequency BFRRE. Our findings may 
also shed light on some of the mechanisms involved in the 
phenomena of exercise- induced overreaching and subse-
quent recovery, and improvements of performance. In ad-
dition, our results may have important implications for the 
interpretations and the choice of time points of muscle size 
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and strength measurements, not only after BFRRE but also 
with conventional heavy resistance exercise. In any case, our 
findings demonstrate that a gradual familiarization to BFRRE 
may be necessary and that it seems important that BFRRE 
is introduced carefully and gradually, to allow the repeated- 
bout effect to take place and to avoid excessive muscular 
stress and damage at the initiation of training. Future research 
should investigate if gradual familiarization can precondition 
against muscle damage at initiation of frequent strenuous 
BFRRE and thereby achieve faster and greater gains in mus-
cle size and strength.
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